About the Authors

Barry Bentley

Affiliation Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

Robyn Branicky

Affiliation Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

Christopher L. Barnes

Affiliations Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom, HHMI Janelia Research Campus, Ashburn, VA, United States of America

Yee Lian Chew

Affiliation Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

Eviatar Yemini

Affiliation Department of Biological Sciences, Columbia University, New York, NY, United States of America

Edward T. Bullmore

Affiliations Department of Psychiatry, University of Cambridge, Cambridge United Kingdom, ImmunoPsychiatry, Alternative Discovery & Development, GlaxoSmithKline R&D, Cambridge United Kingdom

Petra E. Vértes

Contributed equally to this work with: Petra E. Vértes, William R. Schafer

Affiliation Department of Psychiatry, University of Cambridge, Cambridge United Kingdom

William R. Schafer

Contributed equally to this work with: Petra E. Vértes, William R. Schafer

wschafer@mrc-lmb.cam.ac.uk

Affiliation Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

Competing Interests

ETB is employed half-time by the University of Cambridge and half-time by GlaxoSmithKline; he holds stock in GSK. The authors have declared that no competing interests exist.

Author Contributions

Conceptualization: WRS PEV ETB BB. Data curation: BB CLB. Formal analysis: BB CLB PEV. Funding acquisition: WRS ETB. Investigation: RB YLC EY BB. Methodology: BB PEV CLB RB. Project administration: WRS PEV. Resources: RB. Software: BB CLB. Supervision: WRS PEV ETB. Validation: BB CLB EY. Visualization: BB WRS CLB. Writing – original draft: BB WRS. Writing – review & editing: RB PEV ETB YLC.